Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
Avadel Pharmaceuticals EPS Diluted (Quarterly) : 0.0002 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 4.434 |
| Perrigo Co. Plc | -2.874 |
| Iterum Therapeutics Plc | -0.196 |
| GH Research Plc | -0.3057 |
| Cosmo Pharmaceuticals NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.02M |
| Revenue (Quarterly) | 77.47M |
| Total Expenses (Quarterly) | 77.45M |
| Enterprise Value | 2.070B |
| Profit Margin (Quarterly) | 0.03% |
| Earnings Yield | -0.03% |
| Operating Earnings Yield | 0.21% |
| Normalized Earnings Yield | -0.0254 |